PAIYY on OTC

Aesthetic Medical International Holdings Group Ltd

Price unavailable

Last updated Oct 16, 2026.

Overview

Compare with another stock.

TickerPAIYY on OTC
IndustryServices-Specialty Outpatient Facilities, NEC
HeadquartersE9
Incorporated inCayman Islands²
Business address1122 Nanshan Avenue, Nanshan District, Shenzhen, 518000²
Filer categoryNon-accelerated filer²

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Gross profit³⁴⁵⁶⁷$337.8M in 2024−33% since 2018

Net income³⁴⁵⁶⁷-$25.1M in 2024−90% since 2018

Every line of the income statement in the latest annual report, as filed.⁸

Period ending	2025-12-31	2024-12-31	2023-12-31
Revenue	722.9M CNY	755.7M CNY	682.6M CNY
Cost of sales and services rendered	-388.6M CNY	-417.9M CNY	-360.5M CNY
Gross profit	334.2M CNY	337.8M CNY	322.0M CNY
Selling expenses	-226.4M CNY	-241.0M CNY	-232.3M CNY
General and administrative expenses	-102.7M CNY	-100.8M CNY	-138.6M CNY
Operating result	5.2M CNY	-4.0M CNY	-48.8M CNY
Finance income	138.0K CNY	404.0K CNY	78.0K CNY
Finance costs	-8.7M CNY	-8.7M CNY	-14.5M CNY
Other gains/(losses), net	-20.8M CNY	-1.1M CNY	8.4M CNY
Fair value loss of convertible note	0 CNY	0 CNY	-116.0K CNY
Fair value (loss)/gain of investment properties	-31.0K CNY	12.1M CNY	-154.0K CNY
Impairment of goodwill	-500.0K CNY	0 CNY	0 CNY
Loss before income tax	-24.7M CNY	-1.3M CNY	-55.1M CNY
Income tax credit/(expense)	-29.3M CNY	-23.7M CNY	15.1M CNY
Loss for the year	-54.1M CNY	-25.1M CNY	-39.9M CNY
Currency translation differences	1.5M CNY	-302.0K CNY	-790.0K CNY
Revaluation of investment properties upon transfer from property, plant and equipment	0 CNY	0 CNY	-1.5M CNY
Total other comprehensive (loss)/income for the year, net of tax	1.5M CNY	-302.0K CNY	-2.3M CNY
Total comprehensive loss for the year	-52.6M CNY	-25.4M CNY	-42.2M CNY
Owners of the Company	-53.3M CNY	-19.9M CNY	-37.4M CNY
Non-controlling interests	-721.0K CNY	-5.1M CNY	-2.5M CNY
Basic (in Yuan Renminbi per share)	-0.40 CNY	-0.14 CNY	-0.28 CNY
Diluted (in Yuan Renminbi per share)	-0.40 CNY	-0.14 CNY	-0.28 CNY
Owners of the Company	-51.8M CNY	-20.2M CNY	-39.7M CNY
Non-controlling interests	-721.0K CNY	-5.1M CNY	-2.5M CNY

Total assets⁹³⁴⁵⁶⁷$486.2M in 2024−28% since 2018

Total liabilities⁹³⁴⁵⁶⁷$476.9M in 2024−48% since 2018

Shareholders’ equity⁴⁵⁶⁷$9.3M in 2024

Cash³⁴⁵⁶⁷$42.8M in 2024−58% since 2018

Every line of the balance sheet in the latest annual report, as filed.⁸

Period ending	2025-12-31	2024-12-31	2023-12-31
Property, plant and equipment	279.5M CNY	266.2M CNY	304.2M CNY
Investment properties	35.0M CNY	35.1M CNY	22.9M CNY
Intangible assets	31.6M CNY	36.6M CNY	36.9M CNY
Prepayments and deposits	7.1M CNY	6.7M CNY
Deferred income tax assets	23.3M CNY	53.6M CNY
Total non-current assets	376.5M CNY	398.1M CNY
Inventories	18.8M CNY	14.9M CNY
Trade receivables	6.4M CNY	8.8M CNY
Other receivables, deposits and prepayments	42.2M CNY	18.4M CNY
Amounts due from related parties	1.7M CNY	2.2M CNY
Restricted cash	5.1M CNY	1.0M CNY
Cash and cash equivalents	60.3M CNY	42.8M CNY
Total current assets	134.4M CNY	88.1M CNY
Total assets	510.9M CNY	486.2M CNY
Share capital	998.0K CNY	998.0K CNY
Treasury shares	-2.0M CNY	-2.0M CNY
Accumulated losses	-1.3B CNY	-1.2B CNY
Other reserves	1.2B CNY	1.2B CNY
Total equity attributable to owners of parent	-20.6M CNY	30.5M CNY
Non-controlling interests	-22.6M CNY	-21.1M CNY
Total equity	-43.2M CNY	9.3M CNY	33.6M CNY
Borrowings	15.2M CNY	13.7M CNY
Lease liabilities	110.4M CNY	61.1M CNY
Total non-current liabilities	125.6M CNY	74.8M CNY
Trade payables	34.7M CNY	48.4M CNY
Accruals, other payables and provisions	42.4M CNY	43.1M CNY
Contract liabilities	186.1M CNY	193.9M CNY
Borrowings	129.1M CNY	72.2M CNY
Lease liabilities	25.9M CNY	32.3M CNY
Current income tax liabilities	10.3M CNY	12.1M CNY
Total current liabilities	428.6M CNY	402.0M CNY
Total liabilities	554.1M CNY	476.9M CNY
Total equity and liabilities	510.9M CNY	486.2M CNY

Cash from operations³⁴⁵⁶⁷$79.7M in 2024+1528% since 2018

Capital spending³⁴⁵⁶⁷$30.6M in 2024−33% since 2018

Free cash flow³⁴⁵⁶⁷$49.1M in 2024

Every line of the cash flow in the latest annual report, as filed.⁸

Period ending	2025-12-31	2024-12-31	2023-12-31
Cash generated from/(used in) operations	-10.8M CNY	80.2M CNY	74.3M CNY
Income tax paid	-1.4M CNY	-523.0K CNY	-20.0K CNY
Net cash generated from/(used in) operating activities	-12.2M CNY	79.7M CNY	74.3M CNY
Proceeds from disposal of property, plant and equipment	6.6M CNY	66.0K CNY	11.0K CNY
Purchase of and deposit paid for property, plant and equipment	-6.9M CNY	-30.6M CNY	-55.2M CNY
Purchase of and deposit paid for intangible assets	-76.0K CNY	-187.0K CNY	-215.0K CNY
Restricted cash	0 CNY	0 CNY	1.5M CNY
Balances with related parties	0 CNY	0 CNY	717.0K CNY
Loan granted to a third party	-39.7M CNY	-66.0M CNY	0 CNY
Loan repayment from the third party	39.7M CNY	66.0M CNY	0 CNY
Interest income received	138.0K CNY	404.0K CNY	78.0K CNY
Proceeds from disposal of associate	0 CNY	0 CNY	80.0K CNY
Proceeds from disposal of subsidiaries	0 CNY	0 CNY	824.0K CNY
Proceeds from ceased operation of subsidiaries	0 CNY	-1.0K CNY	-44.0K CNY
Net cash used in investing activities	-279.0K CNY	-30.3M CNY	-52.2M CNY
Proceeds from borrowings	80.2M CNY	67.0M CNY	85.2M CNY
Repayment of borrowings	-21.9M CNY	-63.0M CNY	-130.2M CNY
Repayment of lease liabilities	-38.8M CNY	-38.8M CNY	-25.7M CNY
Proceeds from other borrowings	83.0M CNY	92.1M CNY	13.5M CNY
Repayment of other borrowings	-63.0M CNY	-116.3M CNY	-73.1M CNY
Interest paid	-8.7M CNY	-8.7M CNY	-10.1M CNY
Addition of paid-in capital	0 CNY	0 CNY	170.0M CNY
Capital contribution from non-controlling interests	0 CNY	-500.0K CNY	0 CNY
Dividends paid to non-controlling interests	-801.0K CNY	-225.0K CNY	-546.0K CNY
Net cash generated from/(used in) financing activities	29.9M CNY	-68.5M CNY	29.1M CNY
Net increase/(decrease) in cash and cash equivalents	17.4M CNY	-19.2M CNY	51.1M CNY
Effect of changes in foreign exchange rates	0 CNY	-302.0K CNY	-927.0K CNY

Compare Aesthetic Medical International Holdings Group Ltd with another company

Recent filings

Aug 11, 202615-12G
Apr 23, 202620-F
Apr 3, 2026SCHEDULE 13D/A
Aug 19, 20256-K
Apr 25, 202520-F
Jan 21, 2025UPLOAD
Jan 6, 2025CORRESP
Dec 20, 2024CORRESP
Dec 13, 2024SC 13D/A AMENDMENT NO. 3 TO SCHEDULE 13D
Nov 25, 2024UPLOAD
Nov 18, 2024CORRESP
Nov 5, 2024UPLOAD
Oct 31, 20246-K
Oct 23, 2024CORRESP
Oct 8, 2024CORRESP

Every filing from the last three years, summarized. The full record is on SEC EDGAR.¹

Sources

The numbers on this page point here. Each one links to the record it came from.